Form 8-K - Current report:
SEC Accession No. 0000882095-25-000041
Filing Date
2025-10-06
Accepted
2025-10-06 08:17:11
Documents
12
Period of Report
2025-10-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20251006.htm   iXBRL 8-K 26981
  Complete submission text file 0000882095-25-000041.txt   142661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20251006.xsd EX-101.SCH 1795
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20251006_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20251006_pre.xml EX-101.PRE 12521
14 EXTRACTED XBRL INSTANCE DOCUMENT gild-20251006_htm.xml XML 2717
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 251375685
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)